Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

177Lu-labeled NY108 SPECT Imaging in Patients

NCT05815394 is registered in ClinicalTrials.gov with Affiliated Hospital of Jiangnan University as lead sponsor.

NCT NCT05815394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05815394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
177Lu-labeled NY108 SPECT Imaging in Patients
Lead sponsor
Affiliated Hospital of Jiangnan University
Phase
Phase 1
Overall status
Unknown status
Start date
March 3, 2023
Completion date
December 12, 2024
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer